Fulminant Onset of Valproate-Associated Hyperammonemic Encephalopathy

Am J Psychiatry. 2019 Nov 1;176(11):900-903. doi: 10.1176/appi.ajp.2019.18040363.

Authors

Josef Baumgartner¹, Anna Hoeflich¹, Barbara Hinterbuchinger¹, Matthaeus Fellinger¹, Irene Graf¹, Fabian Friedrich¹, Richard Frey¹, Nilufar Mossaheb¹

Affiliation

¹ The Department of Psychiatry and Psychotherapy, Clinical Division of Social Psychiatry (Baumgartner, Hoeflich, Hinterbuchinger, Fellinger, Friedrich, Mossaheb), and the Department of Psychiatry and Psychotherapy, Clinical Division of General Psychiatry (Graf, Frey), Medical University of Vienna.

PMID: 31672038
DOI: 10.1176/appi.ajp.2019.18040363

No abstract available

Keywords: Anticonvulsants; CNS Depressants; Drug Side Effects-other; Inpatient Psychiatry; Mood Disorders-Bipolar.

Publication types

Case Reports

MeSH terms

Adult
Anticonvulsants / adverse effects
Anticonvulsants / blood
Anticonvulsants / pharmacokinetics
Brain Diseases / chemically induced*
Brain Diseases / complications
Humans
Hyperammonemia / chemically induced*
Hyperammonemia / complications
Male
Valproic Acid / adverse effects*
Valproic Acid / blood
Valproic Acid / pharmacokinetics

Substances

Anticonvulsants
Valproic Acid